The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i
The model's full reasoning — Q2 2019 call → NO我们根据指令,需要判断是否在电话会议中出现了具体的负面担忧,并且管理层是否用已观察到的证据进行了反驳。仔细阅读转录文本。 首先,寻找具体的、公司特定的担忧。分析师的问题和管理的评论中是否有提到某种恐惧?例如,关于客户流失、竞争、增长放缓等。 在转录中,分析师的问题主要集中在:销售周期、销售队伍、管道、盈利能力、SMB业务、亚马逊合作等。没有明显的分析师反复追问某个负面事件。管理层也没有明确承认市场担心某个具体问题。 有一个点:关于净收入留存率,Steve提到“retention in enterprise and mid markets has continued to be very consistent and the overall retention remain slightly below historical levels due in part to the impact of the Dex-YP merger last call.” 这里提到了一个负面因素:Dex-YP合并影响了留存率。但这是否是市场担心的具体问题?管理层说“it will take a time to recover from this impact.” 这似乎承认了问题,但没有用已观察到的证据反驳,而是说需要时间恢复。这更像是承认恐惧有效,而不是反驳。 另外,关于SMB业务,管理层说“direct to SMB now makes up less than 10% of the base and we expect that percentage will decline.” 这似乎是在说SMB业务在缩小,但这不是一个负面担忧,而是战略调整。 没有看到分析师反复追问某个具体风险,也没有管理层主动提及市场担心什么。整个电话会议气氛积极,讨论增长、新客户、产品发布等。 因此,没有出现“具体的、公司特定的、活着的担忧”这一半。所以答案应为NO。 但再仔细看,是否有隐含的担忧?比如,关于增长可持续性?分析师问“销售周期是否缩短”等,但这不是恐惧。关于盈利能力,分析师问“增量投资去向”,但也不是恐惧。 因此,答案是否定的。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AVTR | Avantor, Inc. | Q2 2024 | 2024-07-26 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| TYGO | Tigo Energy, Inc. | Q4 2023 | 2024-02-14 | F |
| MET | MetLife, Inc. | Q4 2023 | 2024-02-01 | B+ |
| BBVA | Banco Bilbao Vizcaya Argentaria, S.A. | Q4 2023 | 2024-01-30 | B+ |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| GMED | Globus Medical, Inc. | Q3 2023 | 2023-11-07 | B |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| MAC | The Macerich Company | Q3 2023 | 2023-10-31 | D |
| LNTH | Lantheus Holdings, Inc. | Q2 2023 | 2023-08-03 | C+ |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| TREX | Trex Company, Inc. | Q2 2023 | 2023-07-31 | B+ |
| REYN | Reynolds Consumer Products Inc. | Q1 2023 | 2023-05-10 | C |
| DOCN | DigitalOcean Holdings, Inc. | Q1 2023 | 2023-05-09 | C+ |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| AKR | Acadia Realty Trust | Q4 2022 | 2023-05-06 | B+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| EPR | EPR Properties | Q1 2023 | 2023-04-27 | C+ |
| MEDP | Medpace Holdings, Inc. | Q1 2023 | 2023-04-25 | B+ |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| POOL | Pool Corporation | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| REGN | Regeneron Pharmaceuticals, Inc. | Q4 2022 | 2023-02-03 | C |
| HBAN | Huntington Bancshares Incorporated | Q4 2022 | 2023-01-20 | B |
| A | Agilent Technologies, Inc. | Q4 2022 | 2022-11-21 | B+ |
| PCTY | Paylocity Holding Corporation | Q1 2023 | 2022-11-05 | A |
| TT | Trane Technologies plc | Q3 2022 | 2022-11-02 | A |
| APOG | Apogee Enterprises, Inc. | Q2 2023 | 2022-09-20 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| ZBRA | Zebra Technologies Corporation | Q2 2022 | 2022-08-02 | C+ |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| SHW | The Sherwin-Williams Company | Q2 2022 | 2022-07-27 | D |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| DCGO | DocGo Inc. | Q1 2022 | 2022-05-14 | C |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| EGHT | 8x8, Inc. | Q4 2022 | 2022-05-10 | C+ |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| ABNB | Airbnb, Inc. | Q1 2022 | 2022-05-03 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| BSX | Boston Scientific Corporation | Q1 2022 | 2022-04-27 | B |
| CCK | Crown Holdings, Inc. | Q1 2022 | 2022-04-26 | C+ |
| FR | First Industrial Realty Trust, Inc. | Q1 2022 | 2022-04-21 | A |
| SDIG | Stronghold Digital Mining, Inc. | Q3 2021 | 2021-11-30 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| HSY | The Hershey Company | Q3 2021 | 2021-10-28 | C |
| PEP | PepsiCo, Inc. | Q3 2021 | 2021-10-05 | B |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| PTVE | Pactiv Evergreen Inc. | Q2 2021 | 2021-08-08 | C+ |
| SPG | Simon Property Group, Inc. | Q2 2021 | 2021-08-02 | B |
| GLW | Corning Incorporated | Q2 2021 | 2021-07-27 | B+ |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| VLRS | Controladora Vuela Compañía de Aviación, | Q2 2021 | 2021-07-16 | B+ |
| MAR | Marriott International, Inc. | Q2 2018 | 2018-08-07 | B |
| VALE | Vale S.A. | Q2 2018 | 2018-07-26 | B |
| FICO | Fair Isaac Corporation | Q3 2018 | 2018-07-26 | C+ |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| TRUE | TrueCar, Inc. | Q1 2018 | 2018-05-08 | C |
| TGNA | TEGNA Inc. | Q1 2018 | 2018-05-08 | B+ |
| CVS | CVS Health Corporation | Q1 2018 | 2018-05-02 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| MIDD | The Middleby Corporation | Q4 2017 | 2018-02-28 | C |
| SBUX | Starbucks Corporation | Q1 2018 | 2018-01-26 | C |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| GURE | Gulf Resources, Inc. | Q3 2017 | 2017-11-14 | F |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BCRX | BioCryst Pharmaceuticals, Inc. | Q1 2017 | 2017-05-07 | B |
| ICFI | ICF International, Inc. | Q1 2017 | 2017-05-06 | B+ |
| CGNT | Cognyte Software Ltd. | Q4 2016 | 2017-03-09 | D |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| SEM | Select Medical Holdings Corporation | Q1 2016 | 2016-05-06 | C+ |
| LPSN | LivePerson, Inc. | Q1 2016 | 2016-05-04 | B |
| UVE | Universal Insurance Holdings, Inc. | Q1 2016 | 2016-05-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| VRTS | Virtus Investment Partners, Inc. | Q1 2016 | 2016-04-29 | D |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| BX | Blackstone Inc. | Q1 2016 | 2016-04-21 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
TGI · Q2 2017 → YESThe question is: Is there a specific negative outcome that investors/analysts/market are worried about for THIS company, live on this call, and does management push back with CURRENT, ALREADY-OBSERVED...YES The specific, company-attached fear that is live on the call is that Triumph will continue to face large performance-related charges, cash burn on development programs, and failure to stabilize margins/cash flow despite the transformation (a worry analysts repeatedly probe via questions on the $80M risk, free-cash-use guidance, 747-8/C-17/G650 headwinds, and red programs). Management directly counters it by citing already-observed evidence: Q2 operating income of $70.
ULCC · Q1 2023 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors/analysts/market have been worried about for THIS company, live on this call, AND does management push back with CURRENT, ALREADY-OB...YES The transcript shows a live, company-specific worry about pilot staffing shortages (tied to network changes and new contracts elsewhere) and customer churn/retention due to lower satisfaction scores. Management directly counters both with current evidence: pilot surplus and attrition on target for staffing, plus over 90% repeat business for retention.
HOLX · Q4 2017 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company, and does management push back on that worry by poin...YES The transcript shows a live, company-specific fear centered on Cynosure: investors and analysts are worried that the acquisition will not deliver sustainable growth, that recent sequential declines reflect a lasting salesforce collapse or competitive erosion, and that the business will continue underperforming expectations rather than turning around.